Alzamend Neuro, Inc. (ALZN) Ownership

NASDAQ: ALZNTop holders, insider trades and short interest.

ALZN ownership summary

as of October 18, 2026
Institutions
56.4%
of shares outstanding
Insiders
2.66%
of shares outstanding
Shares outstanding
4.8M
Float
4.8M
shares available to trade
Short interest
2.37%
112K shares short
Days to cover
1.09
short interest down 9.3% vs prior month
  • Institutions 56.35%
  • Insiders 2.66%
  • Other investors 40.98%

ALZN top institutional holders

19 largest
Alzamend Neuro, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Kingsbury Capital Investment Advisors LLC27.54%1.3M$1.7M+762,367 (+134.5%)June 30, 2026
2KMT WEALTH MANAGEMENT, LLC27.54%1.3M$1.7M+1.3M (0.0%)June 30, 2026
3Geode Capital Management, LLC0.55%26K$34,282−19,309 (−42.3%)June 30, 2026
4Vanguard Fiduciary Trust Co0.44%21K$27,326—June 30, 2026
5Vanguard Capital Management, LLC0.16%7,556$9,823+3,156 (+71.7%)June 30, 2026
6Tower Research Capital LLC0.07%3,517$4,572−2,667 (−43.1%)June 30, 2026
7UBS Group AG0.05%2,352$3,058−2,152 (−47.8%)June 30, 2026
8BlackRock Inc0.01%437$568—June 30, 2026
9IFG Advisory, LLC<0.01%22$29+22 (0.0%)June 30, 2026
10SBI Securities Co Ltd<0.01%22$29—June 30, 2026
11Caitong International Asset Management Co., Limited.<0.01%3$4−1 (−25.0%)June 30, 2026
12HARBOR INVESTMENT ADVISORY, LLC0.00%1$1+1 (0.0%)June 30, 2026
13DRW Securities, LLC0.00%——−116,319 (−100.0%)March 31, 2026
14Citigroup Inc0.00%——−5,231 (−100.0%)June 30, 2026
15Morgan Stanley - Brokerage Accounts0.00%——−18,000 (−100.0%)June 30, 2026
16Virtu Financial LLC0.00%——−12,582 (−100.0%)March 31, 2026
17Hartland & Co0.00%——−10,000 (−100.0%)June 30, 2026
18XTX Topco Ltd0.00%——−12,470 (−100.0%)March 31, 2026
19Bank of America Corp0.00%——−43 (−100.0%)March 31, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 19, 5 holders added 2.1M shares and 11 cut 199K.

ALZN top mutual fund and ETF holders

2 largest
Alzamend Neuro, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Fidelity Extended Market Index0.41%20K$25,815−107 (−0.5%)August 31, 2026
2Fidelity Series Total Market Index0.10%4,644$6,037—August 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

ALZN insider transactions

latest 20
Alzamend Neuro, Inc. insider transactions
DateNameTransactionPriceSharesValue
2026-04-14Milton C Ault IIIBuy$1.00108,388$108,388
2025-12-23Milton C Ault IIISell$2.071,851$3,832
2025-12-19William B HorneSell$2.123,333$7,066
2025-10-23Lynne Fahey McgrathSell$2.2930$69
2025-10-09Milton C Ault IIISell$2.3220,397$47,321
2025-10-08Milton C Ault IIISell$2.44101,394$247,401
2025-10-07Milton C Ault IIISell$2.4957,379$142,874
2025-10-06Milton C Ault IIISell$2.4582,033$200,981
2025-10-03Milton C Ault IIISell$2.4465,903$160,803
2025-10-02Milton C Ault IIISell$2.3920,686$49,440
2025-10-01Milton C Ault IIISell$2.3536,777$86,426
2025-09-30Milton C Ault IIISell$2.333,566$8,309
2025-09-29Milton C Ault IIISell$2.3138,324$88,528
2025-09-26Milton C Ault IIISell$2.3137,738$87,175
2025-09-25Milton C Ault IIISell$2.3114,628$33,791
2025-09-24Milton C Ault IIISell$2.3139,140$90,413
2025-09-23Milton C Ault IIISell$2.3843,238$102,906
2025-09-19Milton C Ault IIISell$2.3577,009$180,971
2025-09-18Milton C Ault IIISell$2.4720,870$51,549
2025-09-17Milton C Ault IIISell$2.452,121$5,196

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

ALZN shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns ALZN

Institutional investors own 56.4% of Alzamend Neuro's shares and insiders 2.66%. The largest holder is Kingsbury Capital Investment Advisors LLC with 27.54% of the shares (1.3M), as of June 30, 2026. Among the top 19 institutions, 5 added shares and 11 reduced their stake in the latest filings. Short interest is 2.37% of the float, or 1.09 days of average trading volume. The share count rose 18,275.0% since 2016.

Related: ALZN analyst forecast, ALZN key metrics. See the ALZN stock overview for the latest quote and news.

ALZN ownership FAQ

Who owns the most Alzamend Neuro stock?

The largest shareholders of Alzamend Neuro are Kingsbury Capital Investment Advisors LLC (27.54%), KMT WEALTH MANAGEMENT, LLC (27.54%), Geode Capital Management, LLC (0.55%), Vanguard Fiduciary Trust Co (0.44%), Vanguard Capital Management, LLC (0.16%).

What percentage of Alzamend Neuro is owned by institutions?

Institutions hold 56.4% of Alzamend Neuro's shares outstanding; insiders hold 2.66%.

Which funds own Alzamend Neuro?

The largest fund holders of Alzamend Neuro are Fidelity Extended Market Index (0.41%), Fidelity Series Total Market Index (0.10%).

What is Alzamend Neuro's short interest?

112K shares of Alzamend Neuro were sold short, 2.37% of the float; at the average daily volume it would take 1.09 days to cover.

Are insiders buying or selling Alzamend Neuro?

Of the latest 20 reported insider transactions in Alzamend Neuro (since September 17, 2025), 1 were purchases and 19 were sales.

How many shares of Alzamend Neuro are outstanding?

Alzamend Neuro has 4.8M shares outstanding, of which 4.8M are in the public float.

Biotechnology: ownership